# Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity

> **NCT07638592** · — · COMPLETED · sponsor: **Azienda Sanitaria Locale Napoli 2 Nord** · enrollment: 91 (actual)

## Conditions studied

- Obese Adults
- Hernia Abdominal Wall
- Prehabilitation

## Interventions

- **DRUG:** Tirzepatide prehabilitation

## Key facts

- **NCT ID:** NCT07638592
- **Lead sponsor:** Azienda Sanitaria Locale Napoli 2 Nord
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07638592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07638592, "Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07638592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*